Login to Your Account



Washington Roundup

FDA Approves REMS for Most Powerful Opioids

By Mari Serebrov
Washington Editor

Tuesday, July 10, 2012
In the latest salvo against the growing problem of prescription drug abuse and misuse, the FDA approved a classwide risk evaluation and mitigation strategy (REMS) for extended-release and long-acting opioid drugs.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription